Other relevant news · Mind Medicine Australia
Mind Medicine Australia logo Menu

Other relevant news

This psychoactive plant could save lives—and everyone wants to cash in

National Geographic, 08 March, 2023

Iboga plants smuggled out of Gabon provide most of the world’s ibogaine, a drug that can help heal trauma and addiction. As the plant enters fair trade, officials hope regulation ensures equity and sustainability.

Read more

Psychedelics Could Revolutionize Couples Therapy

Time, 14 March, 2023

“MDMA can build trust, release tension and fear, and erode inhibitions, allowing partners to have hard conversations with compassion and without judgment, says Catherine Auman, a California psychotherapist who coaches clients on how to integrate psychedelics into their lives.”

Read more

Australia will allow prescription MDMA and magic mushrooms for some people with mental illness

ABC News USA, 05 March, 2023

Australian regulators announced in February that psychiatrists will be able to prescribe psilocybin and MDMA as medication for certain mental health conditions starting July 1 of this year. The move makes Australia the first nation to approve the legal use of MDMA and psilocybin.

Read more

Australia is about to legalise MDMA and psilocybin for medicinal use. So how will it work?

ABC News, 03 March, 2023

Just three months out from the legalisation of psychedelic medicines for mental health treatment, questions remain among experts about exactly how the drugs will be administered.

Read more

Does the ‘hype’ on psychedelics match the reality when it comes to mental health?

News.com.au, 27 February, 2023

It sounds crazy doesn’t it? Psychedelic drugs to treat a variety of debilitating mental illness.
But could they be the latest answer to Australia’s spiralling mental health crisis?

Read more

The Promise and Perils of Psychedelics

The New England Journal of Medicine, 23 February, 2023

In this episode of “Intention to Treat,” a study participant and a long-time investigator of hallucinogenic drugs for psychiatric conditions illuminate the effects of psilocybin in patients with depression.

Listen here

The Veterans Fighting to Legalize Psychedelics

The New York Times, 22 February, 2023

In a major shift that would modify laws set half a decade ago, states and cities around the United States are moving to legalize psychedelics for use as a medical treatment.

The sudden change of heart has a lot to do with who is asking for the substances.

Read more

MEPs urge European regulators to move faster on psychedelics

Psychedelic Health, 21 February, 2023

Australia’s recent rescheduling of psilocybin and MDMA is inspiring action across the globe.

A group of Members of the European Parliament have sent two letters calling on regulators to move faster on psychedelic healthcare in Europe, stating that “stagnation is creating a disadvantage for millions of Europeans affected by mental health conditions and substance use disorders”.

Read more

Psychedelics might change mental healthcare. Will investors follow?

CNBC International, 17 February, 2023

Global sales of antidepressant drugs are expected to exceed $20 billion by 2030. Now, some investors are betting that psychedelic therapies can grab a share of that enormous market.

Watch the video here

Is it finally time to change the law around magic mushrooms?

Evening Standard, 16 February, 2023

Anew digital billboard campaign has appeared around London in the past few days, asking one striking question: Could magic mushrooms be medicine?

Read more

Everyone seems to be on psychedelics except me

The Telegraph, 29 January, 2023

Read the full PDF here.

Read more

Australia’s biggest research trial using psychedelics to treat depression to commence in 2023

Swinburne University, 25 January, 2023

Swinburne has signed a $5 million clinical trial research agreement with Woke Pharmaceuticals to embark on Australia’s biggest research trial examining the promise of the active ingredient in psychedelic mushrooms, called ‘psilocybin’, in tackling treatment-resistant depression.

Download (129.7 KB)

Rapid and durable response demonstrated in the first placebo-controlled study exploring a short-duration psychedelic for depression

Psychiatric Times, 25 January, 2023

Small Pharma, a European psychedelic medicine company announced the results of its Phase 2a clinical trial, treating moderate to severe Major Depressive Disorder (MDD) with DMT-assisted therapy. The trial carries special significance, as it is the first-ever clinical trial attempting to treat a mental health disorder with DMT, the shorter-acting chemical cousin to psilocybin.

Read More Here

Scientists are beginning to unravel the effects of psilocybin mushrooms on bipolar disorder

Psypost, 21 January, 2023

Scientists are beginning to unravel the effects of psilocybin mushrooms on bipolar disorder. Research of late has shown psilocybin to improve symptoms of depression, which is particularly burdensome to the quality of life for people with bipolar disorder.

Read more

What We Know About Treating Extreme Grief With Psychedelics

New York Times, 10 January, 2023

In his new memoir, Prince Harry talks about taking psychedelics to deal with the ongoing pain over the death of his mother. Here’s what we know and don’t know about their effectiveness.

Read the full PDF here.

Read more

Australia the world’s psychedelic research capital as Ingenu studies psilocybin and MDMA

The Australian, 10 January, 2023

Australia is emerging as a leading centre for psychedelic medicine trials.

Read the full PDF here.

Read more

In Pursuit of Altered States of Consciousness

Herald, 07 January, 2023

The highs, the lows and the new “normal”, in Pursuit of Altered States of Consciousness. Dive into this intricate article, journeying the spectrum of humanity’s psychedelic experiences and stories.

Read more

MAPS PBC Announces Positive Results from Confirmatory Phase 3 "MAPP2" Trial of MDMA-Assisted Therapy for Treatment of PTSD

PR Newswire, 05 January, 2023

If approved, MAPS PBC’s MDMA-assisted therapy could be the first psychedelic-assisted therapy used to treat a mental health condition.

Read more

What Happens in a Clinical Trial for Psychedelics?

ABC Sydney, 05 January, 2023

Josh Szeps from ABC Sydney speaks to Michael Taylor about his experience as a volunteer part of a clinical trial at the Turner Institute for Brain and Mental Health at Monash University.

Listen Here

New York Lawmakers Introduce Psychedelics Legalization Bill

Forbes, 04 January, 2023

A trio of New York state lawmakers has introduced a bill to legalize natural psychedelics,   including DMT, ibogaine, mescaline, psilocybin and psilocin.

Read more

‘Melding with the MRI machine’: The volunteers taking psychedelic drugs for science

Sydney Morning Herald, 02 January, 2023

Michael Taylor was lying in an MRI machine when he had the most joyous experience of his life. He is one of 60 volunteers participating in PsiConnect, the first psychedelic trial in Australia involving healthy participants.

Read more

686 Deaths Too Many

Herald Sun, 30 December, 2022

SUICIDES in Victoria are at a five-year high, with 686 deaths recorded so far this year.

Read more

Could psychedelics be used to treat mental health disorders?

ABC News, 25 November, 2022

There is hope that psychedelic medicines might hold the key to treating a range of mental health issues — from anxiety to depression and PTSD.

Read more

The Expanding Scope of Psychedelics as Medicines

Blossom in cooperation, and co-published, with Lucid News, 14 November, 2022

How the expanding scope of psychedelic medicine research is demonstrating the effectiveness of a single compound (psilocybin/MDMA) across multiple disorders, from PTSD to headache disorders. 

“Open the Diagnostic and Statistical Manual of Mental Disorders (DSM-V, psychiatrists’ dictionary), pick any disorder, and you’re likely to see psychedelics research being conducted for it.” 

Read more

New psychedelic trial to test whether hallucinogenic drug can help cure smoking addiction

7 News, 13 November, 2022

The US National Institutes of Health has awarded a grant to scientists at Johns Hopkins University, in the first offer of its kind in half a century.

The study, a randomised controlled trial expected to start later this year, will investigate whether psilocybin, the psychedelic compound found in “magic mushrooms”, can help people quit smoking tobacco.

Read more

The Business Trip

The Weekend Australian Magazine, 13 November, 2022

A luxe psychedelic retreat for high-flying corporate types? Will Pavia is all in

Read more

Colorado Voted to Decriminalize Psilocybin and Other Psychedelics

Time, 11 November, 2022

Colorado voters have approved the broadest psychedelic legalization in the U.S., which would decriminalize five psychedelic substances and enable adults to receive psychedelics at licensed centers. The Associated Press called the vote for the measure, Proposition 122, on Friday morning; 92% of the votes were in as of 11 a.m., with 52.3% of voters in favor.

Read more

Researchers experiment with psychedelics to treat post-traumatic stress disorder

7.30, ABC, 09 November, 2022

There are some effective therapies for people suffering from post-traumatic stress disorder, but they don’t work for everyone and with as many as one million Australians living with PTSD, the search for new treatments is gathering steam.

It’s driving a re-examination of treatments involving psychedelic drugs as James Elton reports.

Watch Video Here

With Promise of Legalization, Psychedelic Companies Joust Over Future Profits

The New York Times, 25 October, 2022

Start-ups are filing scores of patent claims on psychedelics such as psilocybin.

Read the PDF here.

Read More

The world's first Phase 3 psilocybin clinical trial is about to commence

New Atlas, 25 October, 2022

The world’s first Phase 3 human trial for day psilocybin therapy with psychological support due to commence by the end of 2022. The trial will enroll close to 1,000 participants and Compass is looking to FDA approval by the end of 2025.

Read More Here

Shroom A Magic Cure

Herald Sun, 24 October, 2022

Melbourne team makes anorexia breakthrough.

Read more

Professor Arthur Christopoulos speaks at Academy of Law and Academy of Science Joint Symposium

Academy of Law and Academy of Science Joint Symposium, 18 October, 2022

Yesterday, Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy & Pharmaceutical Sciences, and inaugural Director of the Neuromedicines Discovery Centre at Monash University, spoke at the Academy of Law and Academy of Science Joint Symposium.

He spoke of the vast divide between science and the law, in reference to the scheduling of medicines, and particularly focusing on psilocybin and MDMA. As the TGA finalises the interim decision on the rescheduling of these medicines, it would be important to keep his words in mind.

Watch Video Here

Psychedelic Medicine Is Going Beyond PTSD and Depression

Lucid News, 13 October, 2022

Though psychedelic treatments for a few major indications get all the headlines, there are many more conditions that psychedelic treatments are being investigated for.

Read more

Psychedelics are Exploding in the Startup Community as Founders Say it Makes Them Better Leaders

FortuneWell , 06 October, 2022

Ayahuasca’s effects may feel like “talk therapy on steroids” because the hallucinations reveal what many interpret as a deeper truth about themselves, their life, or life in general. Often called ayahuasca “teachings,” these visions may provide the type of self-awareness critical to being a good leader. Business leadership research shows that when leaders can regulate their own negative emotional responses, they can better identify their team’s needs and provide them the encouragement or motivation they need.

Read more

Kiwi trial to investigate psilocybin and treatment-resistant depression

NZ Herald, 28 September, 2022

A new trial is set to look into whether psilocybin could provide effective treatment for those with severe depression.

Read more

Researchers Studying Psychedelic Drug as Treatment for Alzheimer’s Disease

High Times, 21 September, 2022

A Toronto-based biotech company is studying a psychedelic drug based on DMT as a treatment for Alzheimer’s disease with a Phase ll clinical trial in Argentina.

Read more

Mushrooms for meds: Psychedelics are changing treatment ways in Israel

Y Net News, 16 September, 2022

Ecstasy for PTSD and ketamine for long-term depression – is this game changer set to revolutionize mental health treatment in Israel and elsewhere?

Read more

Is the Serotonin Hypothesis about Depression Wrong?

Amen Clinics, 30 August, 2022

For over 30 years of clinical practice, Amen Clinics has been saying that a serotonin imbalance may be present in some people with depression, but it is not the only cause of depressive symptoms. Depression is not just one thing. Find out the seven causes of depression that aren’t related to serotonin.

Read more

Psilocybin Study To Investigate the Serotonin System in Autism

Technology Networks, 07 September, 2022

Technology Networks spoke to Tobias Whelan, PhD student at King’s College London and research scientist at COMPASS Pathways, who is conducting the study, to learn more about this first-ever mechanistic study of psilocybin in autistic adults.

Read more

Psychedelic Drugs Take On Depression

Nature Briefing , 24 August, 2022

Mind-altering drugs might provide relief for those who don’t respond to conventional therapies — but does the hype outweigh the hope? What is clear is that new therapies are urgently needed. The coronavirus pandemic has left more people in mental distress than ever before. Psychedelics offer the possibility of relief for people who have no other options.

Read more

'Magic mushroom' psychedelic may help heavy drinkers quit

ABC News, 25 August, 2022

Psilocybin helped heavy drinkers cut back or quit entirely in the most rigorous test of psilocybin for alcoholism.

Read more

Psychedelic Drug Therapy a Breakthrough for Alcohol Dependence?

Medscape, 24 August, 2022

Psilocybin paired with psychotherapy is associated with a robust and sustained decrease in drinking among adults with alcohol use disorder (AUD), new research suggests.

Read the PDF here.

Read more

The long history of psychedelics in religion, from ergot-spiked wine to magic mushrooms

ABC News, 21 August, 2022

In the last century, psychedelics have gone from being at the cutting edge of medical science, to a symbol of the 1960s counterculture, and back again.

Read more

The Need For 100,000 Psychedelic Facilitators Is Real

LA Weekly, 03 August, 2022

The experts are pretty sure it’s going to take 100,000 psychedelic facilitators for the new industry to provide treatment to the masses.

Read more

Canadian patients fighting for psilocybin access sue federal government

National Post, 02 August, 2022

‘This is the landmark case that is going to legalize psychedelics in Canada’

Read more

Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up

Scientific American, 01 August, 2022

Here’s how the psychedelic substance’s legal status has been shifting.

Read more

Biden administration plans for legal psychedelic therapies within two years

The Intercept, 27 July, 2022

A letter from the Health and Human Services Department discloses the anticipated FDA approval of MDMA and psilocybin treatments.

Read more

Major health insurer opens door to psychedelic drugs

The Australian, 26 July, 2022

Health insurer says psychedelics’ medicinal potential is ‘extraordinary’ amid growing evidence MDMA and psilocybin can be used to treat some mental illnesses.

Read the full PDF here.

Read more

Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’

The Age, 23 July, 2022

Microdosing is a different way of consuming psychedelic medicines, which involves regularly taking small amounts of a psychedelic.

Read more

Biotech Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

The Australian, 21 July, 2022

In a groundbreaking development, the US FDA has just approved a clinical trial studying the effects of naturally derived psychedelic medicines.

Read the PDF here.

Read more

Brains, genes and chemical imbalances – how explanations of mental illness affect stigma

The Conversation, 20 July, 2022

For three decades, people have been deluged with information suggesting that depression is caused by a “chemical imbalance” in the brain – namely an imbalance of a brain chemical called serotonin. However, our latest research review shows that the evidence does not support it.

Read more

Psychedelics for mental health treatment

ABC Nightlife, 11 July, 2022

Writer Michael Pollan discusses how psychedelics are being used now and into the future, to successfully treat people with a range of disorders, addictions and mental illnesses.

Listen now

Can microdosing psychedelics improve your mental health? Here's what the science says

ABC News, 03 July, 2022

Early results from trials on the therapeutic potential of large doses (macrodosing) of psychedelics have been promising.

Read more

Psychedelics Give a Glimpse of Enlightenment

Psychology Today, 03 July, 2022

Our brains may be filters that are inhibiting us from experiencing reality.

Read more

Mark Turner MLA speaks at the Legislative Assembly of the Northern Territory

Mark Turner MLA: Member for Blain , 28 June, 2022

Mark Turner MLA advocates for access to psychedelic-assisted psychotherapies at the Legislative Assembly of the Northern Territory.

Read more

ACT government agrees to decriminalise small amounts of illicit drugs, such as ice, heroin and cocaine

ABC News, 09 June, 2022

The ACT is set to become the first Australian jurisdiction to decriminalise small amounts of commonly used illicit drugs, such as ice, heroin, cocaine and speed.

Read more

‘As legal as garlic’: High times in Thailand as marijuana is decriminalised

The Sydney Morning Herald, 08 June, 2022

Thailand will on Thursday become the first country in Asia to effectively legalise marijuana in a landmark move its government hopes will supercharge its wellness and tourism industries and generate as much as 10 billion baht ($400 million) per year.

Read more

How psychedelic drugs might treat depression

BBC, 07 June, 2022

Hallucinogenic mushrooms have shown promise for their medical benefits, but we are only now beginning to understand how they might help to treat depression.

Read more

New Study To Evaluate Psilocybin’s Therapeutic Potential On Autistic Adults

Neuroscience News, 04 June, 2022

A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.

Read more

Psychedelic retreats target stressed-out corporate executives

Australian Financial Review, 02 June, 2022

New businesses are focusing on jurisdictions where drugs such as psilocybin and ketamine are legal, betting they’ll be able to expand when more places decriminalise popular substances.

Read more

‘We spark curiosity’: how the psychedelics industry is taking on Davos

The Guardian, 01 June, 2022

The Psychedelic House of Davos, a satellite event happening in conjunction with the World Economic Forum, was a ‘genius strategy’ to build credibility, say experts.

Read more

A Balm for Psyches Scarred by War

The New York Times, 29 May, 2022

MDMA-assisted treatment for post-traumatic stress disorder “represents real hope for long-term healing,” health experts say.

Read the full PDF here.

Read more

Israeli company reveals nasal spray of psychedelic mushrooms

Al-Monitor, 09 May, 2022

Madrigal Mental Care says the spray treats post-traumatic stress disorder, anxiety and other mental challenges. Some experts believe magic mushrooms have health benefits, though they come with risks.

Read more

COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression

Globe News Wire, 03 May, 2022

Positive early signals seen in two investigator-initiated studies presented at the Society of Biological Psychiatry Annual Meeting in New Orleans.

Read more

Trending Clinical Topic: Psychedelics

MedScape, 22 April, 2022

A new study examined changes in specific neurotransmitter systems and brain regions that may be responsible for various experiences associated with a psychedelic “trip”.

Read more

Australian researchers trialling magic mushroom active ingredient as antidepressant

9 News, 27 April, 2022

Sydney researchers are testing psilocybin as an alternative to antidepressants.

Read more

GoDaddy Billionaire Bob Parsons Believes Psychedelics Can Heal Trauma—And He’s Putting His Money (And Brain) On The Line

Forbes, 17 April, 2022

The Marine infantryman still suffers from PTSD from his tour in Vietnam but credits LSD and MDMA with helping him “come home.” Now he’s on a mission to help other veterans.

Read more

‘Magic mushrooms’ for PTSD therapy? Vets help sway conservatives

LA Times, 16 April, 2022

Matthew Butler spent 27 years in the Army, but it took a day in jail to convince him that his post-traumatic stress disorder was out of control.

Read more

Mushrooms’ magic compound latest hope to relieve depression

The Australian, 12 April, 2022

Early tests show lasting effects of brain ‘rewiring’ following controlled ‘trips’

Read the full PDF.

Read more

Psychedelic frees up depressed brain, study shows

BBC News, 12 April, 2022

Psilocybin appears to free up the brains of people with severe depression in a way that other antidepressants do not, a study has found.

Read more

What the science says about microdosing

Australian Financial Review, 08 April, 2022

Scientists have insight into what happens when someone takes enough psychedelics to experience hallucinogenic effects. But little research has been conducted on the effects of small doses.

Read the full PDF here.

Read more

6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in 'magic' mushrooms after authorities eased rules

Business Insider, 07 April, 2022

Six terminally ill cancer patients in Canada received the country’s first legally produced psilocybin under new rules about access to the substance.

Read more

Psychedelics may ease cancer patients’ depression, anxiety

Washington Post, 02 April, 2022

Evidence indicates that psychedelics could reduce the end-of-life anxiety that many cancer patients experience.

Read more

The Next Big Addiction Treatment

New York Times, 31 March, 2022

Psilocybin combined with therapy is emerging as one of the most effective psychedelic therapies.

Read the PDF article here.

Read more

Why microdosing is gaining momentum in Australia

Australian Financial Review, 24 March, 2022

Microdosing psychedelic drugs has been a trend in Silicon Valley that’s taking off here. But does a micro trip help you make better decisions at work?

Read the full PDF article here.

Read more

LSD, a future anti-anxiety pill?

McGill University Health Centre, 18 March, 2022

A study conducted by Gabriella Gobbi, MD, Professor and Head of the Neurobiological Psychiatry Unit in the Department of Psychiatry, and her team demonstrates for the first time that regular administration of low doses of LSD (lysergic acid diethylamide) reduces anxiety symptoms through neurobiological mechanisms that are similar to those of selective serotonin reuptake inhibitors (SSRIs).

Read more

Johns Hopkins, Yale, and NYU are teaming up to tackle a key bottleneck that will arise as psychedelics come to market

Business Insider, 11 March, 2022

As psychedelics treatments move closer to regulatory approval, there’s an issue looming in the industry: the lack of trained professionals who can handle such powerful compounds.

Read more

MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests

PsyPost, 11 March, 2022

New research provides evidence that MDMA-assisted psychotherapy can improve and extend lives of patients with chronic and severe post-traumatic stress disorder while also reducing healthcare costs.

Read more

Oklahoma House Passes Psilocybin Decriminalization Bill

Psychedelics Spotlight, 09 March, 2022

On Monday, the state’s Republican-controlled House of Representatives voted overwhelmingly, 62-30, to pass House Bill 3414, introduced by Rep. Daniel Pae (R).

Read more

4 Signs the Psychedelics Movement Is Unstoppable

Psychedelics Spotlight, 28 February, 2022

Dr. Nora Volkow, the Director of the National Institute on Drug Abuse, said earlier this year that the psychedelics “train has left the station,” and here are four big reasons to agree wholeheartedly.

Read more

Psilocybin Treatment for Major Depression Effective for up to a Year for Most Patients

News Medical, 15 February, 2022

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.

Read more

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia: